Portsmouth Industries has stated that in the market for their medical imaging product, their strategy is to grow their market share in the premium segment by leveraging their research and development capabilities to produce machines with greater resolution for the most challenging cases of spinal degeneration. An analyst examining their financials for evidence that Portsmouth is indeed successfully pursuing this strategy would least appropriately look for:

a.		an increase in net revenue.
b.		an increase in average unit prices.
c.		decreasing cost of goods sold as a percentage of net sales.